Litigation Details for SHIRE LLC v. COREPHARMA, LLC (D.N.J. 2014)
✉ Email this page to a colleague
SHIRE LLC v. COREPHARMA, LLC (D.N.J. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-09-12 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:145 Patent Infringement | Assigned To | William J. Martini |
Jury Demand | None | Referred To | Mark Falk |
Parties | SHIRE LLC | ||
Patents | 6,322,819; RE41,148; RE42,096 | ||
Attorneys | CYNTHIA STENCEL BETZ | ||
Firms | McCarter and English, LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SHIRE LLC v. COREPHARMA, LLC
Details for SHIRE LLC v. COREPHARMA, LLC (D.N.J. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-09-12 | 1 | System,” is a reissue of U.S. Patent. No. 6,322,819 (“the ’819 Patent”), which issued on November 27,…States Reissued Patent Nos. RE42,096 (“the ’096 Patent”) and RE41,148 (“the ’148 Patent”). Shire seeks… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…. This civil action for patent infringement arises under the patent laws of the United States, including…and alleges infringement of the ’096 Patent and the ’148 Patent. This Court has jurisdiction over the | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |